This Is What Whales Are Betting On Horizon Therapeutics
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Horizon Therapeutics (NASDAQ:HZNP), with 70% of detected trades showing bearish expectations. The majority of trades are calls, with a total amount of $4,816,733. Whales have been targeting a price range from $80.0 to $115.0 for Horizon Therapeutics over the last 3 months. The price of HZNP is currently up 2.23% at $115.25, but RSI indicators suggest the stock may be overbought.
September 01, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A significant investor has taken a bearish stance on Horizon Therapeutics, with the majority of trades being calls. The stock price is currently up, but may be overbought.
The bearish stance taken by a significant investor, combined with the fact that the majority of trades are calls, suggests a potential decrease in the stock price. Additionally, the current price is at the upper end of the targeted range, and RSI indicators suggest the stock may be overbought, which could lead to a price correction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100